IMITREX (GlaxoSmithKline LLC)


Welcome to the PulseAid listing for the IMITREX drug offered from GlaxoSmithKline LLC. This Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: GlaxoSmithKline LLC
NON-PROPRIETARY NAME: sumatriptan
SUBSTANCE NAME: SUMATRIPTAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
ROUTE: NASAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1997-09-18
END MARKETING DATE: 0000-00-00


IMITREX HUMAN PRESCRIPTION DRUG Details:

Item DescriptionIMITREX from GlaxoSmithKline LLC
LABELER NAME: GlaxoSmithKline LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/1)
START MARKETING DATE: 1997-09-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0173-0523_f797155f-7edf-4ccb-be60-890560311694
PRODUCT NDC: 0173-0523
APPLICATION NUMBER: NDA020626

Other SUMATRIPTAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline LLCIMITREX
Lannett Company, Inc.Sumatriptan
Physicians Total Care, Inc.SUMATRIPTAN
Sandoz IncSUMATRIPTAN